Dachaigh › Cancer Ovarian
Sgrùdaidhean clionaigeach Cancer Ovarian a’ fastadh anns na SA
Tha 263 sgrùdaidhean airson Cancer Ovarian a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Houston, TX89 sgrùdaidhean
- New York City, NY69 sgrùdaidhean
- Boston, MA61 sgrùdaidhean
- Los Angeles, CA50 sgrùdaidhean
- Nashville, TN49 sgrùdaidhean
- Arlington, VA46 sgrùdaidhean
- Philadelphia, PA44 sgrùdaidhean
- Columbus, OH39 sgrùdaidhean
- St. Louis, MO38 sgrùdaidhean
- Chicago, IL36 sgrùdaidhean
- San Antonio, TX31 sgrùdaidhean
- Cleveland, OH30 sgrùdaidhean
- Pittsburgh, PA30 sgrùdaidhean
- Seattle, WA30 sgrùdaidhean
- Atlanta, GA29 sgrùdaidhean
- Rochester, MN29 sgrùdaidhean
- Dallas, TX28 sgrùdaidhean
- Oklahoma City, OK28 sgrùdaidhean
- Queens, NY28 sgrùdaidhean
- Durham, NC27 sgrùdaidhean
- Portland, OR27 sgrùdaidhean
- Detroit, MI26 sgrùdaidhean
- Aurora, CO25 sgrùdaidhean
- Baldwin Park, CA25 sgrùdaidhean
- Minneapolis, MN24 sgrùdaidhean
- San Diego, CA24 sgrùdaidhean
- Grand Rapids, MI24 sgrùdaidhean
- Birmingham, AL23 sgrùdaidhean
- Washington, DC23 sgrùdaidhean
- Miami, FL23 sgrùdaidhean
- Orlando, FL22 sgrùdaidhean
- Baltimore, MD22 sgrùdaidhean
- New Haven, CT21 sgrùdaidhean
- Tampa, FL21 sgrùdaidhean
- Edison, NJ20 sgrùdaidhean
- Salt Lake City, UT19 sgrùdaidhean
- Cincinnati, OH19 sgrùdaidhean
- Mountain View, CA19 sgrùdaidhean
- San Francisco, CA19 sgrùdaidhean
- Milwaukee, WI17 sgrùdaidhean
Le stàit
- Alabama27 sgrùdaidhean
- Alaska7 sgrùdaidhean
- Arizona26 sgrùdaidhean
- Arkansas11 sgrùdadh
- California105 sgrùdaidhean
- Colorado44 sgrùdaidhean
- Connecticut28 sgrùdaidhean
- Delaware5 sgrùdaidhean
- Florida81 sgrùdaidhean
- Georgia35 sgrùdaidhean
- Hawaii7 sgrùdaidhean
- Idaho4 sgrùdaidhean
- Illinois49 sgrùdaidhean
- Indiana23 sgrùdaidhean
- Iowa10 sgrùdaidhean
- Kansas10 sgrùdaidhean
- Kentucky25 sgrùdaidhean
- Louisiana19 sgrùdaidhean
- Maine9 sgrùdaidhean
- Maryland40 sgrùdaidhean
- Massachusetts67 sgrùdaidhean
- Michigan50 sgrùdaidhean
- Minnesota53 sgrùdaidhean
- Mississippi6 sgrùdaidhean
- Missouri41 sgrùdaidhean
- Montana10 sgrùdaidhean
- Nebraska15 sgrùdaidhean
- Nevada11 sgrùdadh
- New Hampshire4 sgrùdaidhean
- New Jersey40 sgrùdaidhean
- New Mexico16 sgrùdaidhean
- New York96 sgrùdaidhean
- North Carolina44 sgrùdaidhean
- North Dakota7 sgrùdaidhean
- Ohio70 sgrùdaidhean
- Oklahoma31 sgrùdaidhean
- Oregon34 sgrùdaidhean
- Pennsylvania69 sgrùdaidhean
- Rhode Island16 sgrùdaidhean
- Sgìre Cholumbia7 sgrùdaidhean
- South Carolina17 sgrùdaidhean
- South Dakota16 sgrùdaidhean
- Tennessee55 sgrùdaidhean
- Texas122 sgrùdaidhean
- Utah29 sgrùdaidhean
- Virginia57 sgrùdaidhean
- Washington38 sgrùdaidhean
- West Virginia10 sgrùdaidhean
- Wisconsin29 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
A’ fastadhÌre 2
Gach aois · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04585750Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
A’ fastadhSgrùdadh amharc
Aoisean 2 gu 100 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT01950572Distance-Based Exercise to Preserve Function and Prevent Disability
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07059884A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06465069Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
A’ fastadhÌre 1
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04847063Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
A’ fastadhÌre 1
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06885697A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06270706Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
A’ fastadhSgrùdadh amharc
Aoisean 3 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT01441089Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
A’ fastadhÌre 2
Aoisean 18 gu 72 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT01174121A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
A’ fastadhÌre 1
Aoisean 19 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06586957A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 1 Dàmh 2026 · NCT07024784A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06172478177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07189871TLR9 Immunotherapy for Peritoneal Carcinomatosis
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07658196Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 1 Dàmh 2026 · NCT07851025Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT04751435The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07285044A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07278336A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07814248Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07360314First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT06799065A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT05877599A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 29 Sult 2026 · NCT05128825Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.